Herpes Cure Research in 2027: Vaccines, Gene Editing and New Drugs
HSV-1 and HSV-2 together infect more than 4 billion people. WHO estimates that about 3.8 billion people under 50 carry HSV-1 and roughly 520 million people...
Read MoremRNA vaccines
6 articles tagged with this topic
Herpes Vaccine Candidates in 2027: Where Every Trial Stands
No herpes vaccine is approved, and none will reach the public in 2027. The field shrank over the past three years. GSK dropped its candidate in 2024, and...
Read More
Herpes Vaccine Candidates in 2026: Where Every Trial Stands
Editorial note: This tracker is no longer updated. For the current status of every vaccine candidate, see our 2027 herpes vaccine tracker. There is no approved...
Read More
Herpes Cure Research in 2026: Vaccines, Gene Editing and New Drugs
Editorial note: This page is no longer updated. For the latest on pritelivir's FDA review, Gilead's weekly pill and gene editing trials, see our herpes cure...
Read MoreHerpes Vaccine Outlook From May 2025: Why 2026 Was Always Unlikely
Editorial note: This article was written in May 2025 and reflects the herpes vaccine landscape as it stood at that time. Since then, Moderna has stopped its...
Read More
Herpes Vaccine Candidates in 2025: Progress and Prospects
Editorial note: This article was written in 2025 and covers HSV vaccine candidates as they stood at that time. Since then, Moderna has stopped mRNA-1608...
Read More